ID: ALA1270534

Max Phase: Preclinical

Molecular Formula: C22H22N4O

Molecular Weight: 358.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1nc(N)nc(N)c1C#CCc1cc(OC)ccc1-c1ccccc1

Standard InChI:  InChI=1S/C22H22N4O/c1-3-20-19(21(23)26-22(24)25-20)11-7-10-16-14-17(27-2)12-13-18(16)15-8-5-4-6-9-15/h4-6,8-9,12-14H,3,10H2,1-2H3,(H4,23,24,25,26)

Standard InChI Key:  XOGAWBOINWDZML-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 135 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.45Molecular Weight (Monoisotopic): 358.1794AlogP: 3.47#Rotatable Bonds: 4
Polar Surface Area: 87.05Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.12CX LogP: 4.55CX LogD: 4.37
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -0.39

References

1. Beierlein JM, Karri NG, Anderson AC..  (2010)  Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.,  53  (20): [PMID:20882962] [10.1021/jm100727t]

Source